Logo

DTSS

Datasea Inc.

DTSS

Datasea Inc. NASDAQ
$1.23 -3.25% (-0.04)

Market Cap $10.54 M
52w High $3.10
52w Low $1.03
Dividend Yield 0%
P/E -4.1
Volume 30.60K
Outstanding Shares 8.57M

Income Statement

Period Revenue Operating Expense Net Income Net Profit Margin Earnings Per Share EBITDA
Q1-2026 $13.814M $1.458M $-201.159K -1.456% $-0.026 $263.592K
Q4-2025 $19.725M $1.648M $-204.429K -1.036% $-0.026 $248.22K
Q3-2025 $10.354M $2.067M $-1.783M -17.221% $-0.25 $-1.404M
Q2-2025 $20.456M $1.656M $-1.136M -5.555% $-0.16 $-928.246K
Q1-2025 $21.081M $2.228M $-1.962M -9.307% $-0.49 $-1.945M

Balance Statement

Period Cash & Short-term Total Assets Total Liabilities Total Equity
Q1-2026 $679.727K $4.657M $4.564M $92.974K
Q4-2025 $620.807K $6.736M $3.794M $2.952M
Q3-2025 $866.737K $6.154M $3.322M $2.842M
Q2-2025 $268.101K $5.904M $2.677M $3.236M
Q1-2025 $937.606K $7.957M $3.892M $4.102M

Cash Flow Statement

Period Net Income Cash From Operations Cash From Investing Cash From Financing Net Change Free Cash Flow
Q1-2026 $-201.026K $879.299K $-1.551M $792.022K $124.457K $879.3K
Q4-2025 $-204.649K $-589.224K $-41.421K $391.92K $-245.93K $-630.645K
Q3-2025 $3.098M $-197.884K $-86.249K $894.322K $598.636K $3.712M
Q2-2025 $-1.128M $-854.917K $-3.91M $4.168M $-669.505K $-4.765M
Q1-2025 $-1.971M $-732.655K $-47.52K $1.491M $756.344K $-780.175K

Revenue by Products

Product Q2-2025Q3-2025Q4-2025Q1-2026
Other Member
Other Member
$0 $0 $0 $0
Others Member
Others Member
$0 $0 $0 $0

Five-Year Company Overview

Income Statement

Income Statement Datasea’s income statement looks like that of a very early-stage business. Revenue has only recently started to show up and is still very small, while the company has reported losses each year. The loss levels suggest the business is still in “build and experiment” mode rather than mature commercial scale. The positive angle is that revenue is at least moving up from almost nothing, but the core story is still one of spending ahead of income.


Balance Sheet

Balance Sheet The balance sheet appears extremely light, with very limited recorded assets and no meaningful debt, but now slipping into negative equity. Negative equity typically means accumulated losses have eaten through the original capital base, which can be a warning sign about financial resilience. The lack of reported debt reduces the risk of creditors forcing pressure, but it also suggests the company is highly dependent on new equity funding, partners, or contract advances to keep going. Overall, the financial cushion looks thin, so access to capital is a key ongoing risk.


Cash Flow

Cash Flow Cash flow figures indicate the business is not yet self-funding. Operating cash flow has been slightly negative in most recent years, and free cash flow mirrors that pattern, with essentially no large investments in physical assets. This points to a model that is light on equipment spending but still requires regular cash to cover operating and development costs. In practice, Datasea likely relies on external financing and new business wins to support operations until the technology becomes commercially scaled.


Competitive Edge

Competitive Edge Competitively, Datasea is trying to stand out by combining advanced acoustic technologies with AI-driven 5G digital services. Its niche focus on “acoustics plus neurology,” sterilization, health wearables, and specialized AI marketing systems gives it a differentiated story compared with generic software or AI firms. The portfolio of patents and links with research institutions, plus some sizable announced contracts, strengthen its positioning and provide a form of technological moat. At the same time, it operates in fast-moving fields where large, well-funded technology and healthcare players could respond quickly, so execution speed and proof of real-world adoption are critical.


Innovation and R&D

Innovation and R&D Innovation is clearly the centerpiece of Datasea’s strategy. The company is pushing into unconventional areas like ultrasound-based health devices, acoustic sterilization products, sleep aids, and pet-care devices, while also building a 5G-AI platform for digital marketing and enterprise services. Its work with brain-related applications and potential brain-computer interface uses shows a willingness to pursue cutting-edge, higher-risk R&D. The big question is how quickly and reliably these projects can move from lab and prototype stages into repeatable, regulated, and profitable products and subscription services.


Summary

Overall, Datasea looks like a high-innovation, high-uncertainty technology company. The story is strong on vision, patents, and differentiated technology, particularly in acoustic health tech and AI-driven digital services. However, the financials reflect a company still in the early commercialization phase: very small revenues, recurring losses, thin balance sheet, and modest but mostly negative cash flows. Future outcomes will likely hinge on whether the company can turn its announced contracts and product pipeline into steady, scalable revenue while securing enough funding to bridge the gap. For now, it remains a speculative, early-stage profile with both notable technological promise and meaningful financial and execution risk.